These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 31805277

  • 1. MiR-501-3p functions as a tumor suppressor in non-small cell lung cancer by downregulating RAP1A.
    Lu J, Zhou L, Wu B, Duan Y, Sun Y, Gu L, Xu D, Du C.
    Exp Cell Res; 2020 Feb 01; 387(1):111752. PubMed ID: 31805277
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression.
    Liu J, Tian W, Zhang W, Jia Y, Yang X, Wang Y, Zhang J.
    Biomed Pharmacother; 2019 Jun 01; 114():108847. PubMed ID: 30970294
    [Abstract] [Full Text] [Related]

  • 3. Dysregulated LINC00961 Contributes to the Vitality and Migration of NSCLC Via miR-19a-3p/miR-19b-3p/miR-125b-5p.
    Sui J, Zhao Q, Zhang Y, Liang G.
    DNA Cell Biol; 2022 Mar 01; 41(3):319-329. PubMed ID: 35244469
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH, Wu G, Cai Q, Gao XC, Tong F, Zhou R, Zhang RG, Dong JH, Hu Y, Dong XR.
    J Hematol Oncol; 2017 Jun 19; 10(1):125. PubMed ID: 28629431
    [Abstract] [Full Text] [Related]

  • 5. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
    Guo D, Wang Y, Ren K, Han X.
    Exp Cell Res; 2018 Jan 01; 362(1):172-179. PubMed ID: 29133127
    [Abstract] [Full Text] [Related]

  • 6. MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway.
    Huang M, Liao X, Li L, Li G, Chen M.
    Tissue Cell; 2021 Dec 01; 73():101672. PubMed ID: 34736163
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W, Wang J, Liu S, Wang S, Cheng Y, Zhou W, Duan C, Zhang C.
    J Exp Clin Cancer Res; 2016 May 10; 35():76. PubMed ID: 27164951
    [Abstract] [Full Text] [Related]

  • 8. MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2.
    Liu B, Li J, Zheng M, Ge J, Li J, Yu P.
    Life Sci; 2017 Nov 01; 188():87-95. PubMed ID: 28866101
    [Abstract] [Full Text] [Related]

  • 9. MiroRNA-188 Acts as Tumor Suppressor in Non-Small-Cell Lung Cancer by Targeting MAP3K3.
    Zhao L, Ni X, Zhao L, Zhang Y, Jin D, Yin W, Wang D, Zhang W.
    Mol Pharm; 2018 Apr 02; 15(4):1682-1689. PubMed ID: 29528232
    [Abstract] [Full Text] [Related]

  • 10. MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer.
    Li W, Cui Y, Wang D, Wang Y, Wang L.
    Biochem Biophys Res Commun; 2019 Feb 12; 509(3):647-656. PubMed ID: 30611568
    [Abstract] [Full Text] [Related]

  • 11. Role of miR-337-3p and its target Rap1A in modulating proliferation, invasion, migration and apoptosis of cervical cancer cells.
    Cao XM.
    Cancer Biomark; 2019 Feb 12; 24(3):257-267. PubMed ID: 30883336
    [Abstract] [Full Text] [Related]

  • 12. MiRNA-500a-3p inhibits cell proliferation and invasion by targeting lymphocyte antigen 6 complex locus K (LY6K) in human non-small cell lung cancer.
    Liao XH, Xie Z, Guan CN.
    Neoplasma; 2018 Sep 19; 65(5):673-682. PubMed ID: 30249107
    [Abstract] [Full Text] [Related]

  • 13. MiR-126-3p suppresses the growth, migration and invasion of NSCLC via targeting CCR1.
    Liu R, Zhang YS, Zhang S, Cheng ZM, Yu JL, Zhou S, Song J.
    Eur Rev Med Pharmacol Sci; 2019 Jan 19; 23(2):679-689. PubMed ID: 30720175
    [Abstract] [Full Text] [Related]

  • 14. MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1.
    Yang W, Zhou C, Luo M, Shi X, Li Y, Sun Z, Zhou F, Chen Z, He J.
    Oncotarget; 2016 Mar 29; 7(13):16703-15. PubMed ID: 26934648
    [Abstract] [Full Text] [Related]

  • 15. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
    Lu YJ, Liu RY, Hu K, Wang Y.
    Tumour Biol; 2016 Sep 29; 37(9):12685-12695. PubMed ID: 27448300
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
    Yang Y, Sun Y, Wu Y, Tang D, Ding X, Xu W, Su B, Gao W.
    Mol Carcinog; 2018 Jul 29; 57(7):842-853. PubMed ID: 29566281
    [Abstract] [Full Text] [Related]

  • 17. miR-140-3p inhibits progression of non-small cell lung cancer by targeting Janus kinase 1.
    Hu C, Zou Y, Jing LL.
    J Biosci; 2020 Jul 29; 45():. PubMed ID: 32345774
    [Abstract] [Full Text] [Related]

  • 18. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y, Zhang F, Zhu C, Geng L, Tian T, Liu H.
    Oncotarget; 2017 Mar 14; 8(11):17785-17794. PubMed ID: 28147312
    [Abstract] [Full Text] [Related]

  • 19. miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.
    Yang D, Wang JJ, Li JS, Xu QY.
    Oncol Res; 2018 May 07; 26(4):519-528. PubMed ID: 28734041
    [Abstract] [Full Text] [Related]

  • 20. MiR-296-3p may affect the proliferation and migration of non-small cell lung cancer cells via regulating RABL3.
    Ge T, Wu HC, Zhou YY, Shen SM, Zhu LG, You GX.
    Eur Rev Med Pharmacol Sci; 2019 Jul 07; 23(13):5823-5830. PubMed ID: 31298353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.